I don't think a user-friendly report is any more required than a user-friendly of a biotech's efficiency and safety data needs to be user friendly. With biotechs some of us just have to rely on other analysts to dumb it down for us is all. I believe the Islechem report being difficult for armchair analysts to understand won't matter either. Smarter money with deeper pockets will understand it. And analysts with JBII on NASDAQ will help in addition to big media.
BS. It's not written in Latin, lol. JBII has chemists on staff that will have no problem 'translating' technical reports into everyday language that people understand. And I'm sure that Islechem will have some type of summary of the report............z
Market Data 
Markets 
AI
